Heathcare generates a vast amount of data and the industry has only recently begun to leverage it in transformative ways.
In this report by datma, it discusses the challenges and limitations of centralized data monetization models, including misaligned business incentives and the operational burden of preparing data for external use.
While expanding access to VBC in primary care is indeed an important goal, we must keep in mind that the vast majority of healthcare expenses are in specialty care areas like oncology, where costs continue to rise without improved patient outcomes.
In a conversation with MedCity News Editor-in-Chief Arundhati Parmar, Personify Health Chief Medical Officer Jeff Jacques talks about the different types of GLP-1 drugs, what portion of employers currently offer the medications, and how many employers are considering making them part of their health benefit offering in the future.
No comments